Description: This is the 1975 Report on Group Life Insurance Mortality.

Description: This Society of Actuaries Research Brief has been constructed to highlight some of the key features of the COVID-19 epidemic and contemplate the risks for the actuarial profession to consider in their work.

Description: Summarizes the results of a follow-up survey of a panel of experts on COVID-19 to see how views on the disease’s impact on future U.S. mortality may have changed.

Description: The SOA has collaborated with LIMRA, Reinsurance Group of America (RGA), and TAI on an ongoing effort to analyze the impact of COVID-19 on the individual life insurance industry’s mortality experience. The data collected for this study included 2.8 million deaths from life insurance policies covering the period January 1, 2015 to September 30, 2020.

Description: Impact of COVID-19 on Future U.S. Mortality: Expert Opinion Survey 2

Description: The attached report presents the results of a survey whose purpose was to explore life insurance company practices regarding the use of a mortality improvement assumption in the pricing of life insurance products. The survey distinguished between updating base mortality tables for historical mortality improvement versus projecting mortality improvement into the future.

Description: The Society of Actuaries Research Institute’s Aging and Retirement Strategic Research Program is pleased to make available a brief report on the impact of COVID-19 on financial stress.

Description: This report summarizes industry mortality experience for the period 2009 - 2016. This report is updated on a mostly annual basis and based on information aggregated from industry VM-51 submissions

Description: This is a report on the results of a survey, conducted during July and August 2008, on the current practices and reactions related to life settlements. A life settlement is a financial transaction in which a policy owner possessing an unneeded or unwanted life insurance policy, sells the policy to a third party for more than the cash value offered by the life insurance company at the time of sale.